Amici Pharma, Inc
16 drugs in NADAC|16 Generic,0 Brand
Amici Pharma, Inc lists 16 NDCs in the CMS NADAC file (16 generic, 0 brand), at an average NADAC of $0.47 per unit, with a week-over-week move of -1.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
16
16G / 0B
Avg Price / Unit
$0.4685
$0.06 – $4.57
Avg 7d Change
-1.05%
Across 16 drugs with changes
7d Activity
of 16 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
enalapril maleate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Angiotensin Converting Enzyme Inhibitor therapeutic class
Review the broader class where Amici Pharma, Inc has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Amici Pharma, Inc make?
Amici Pharma, Inc lists 16 NDCs in the CMS NADAC file — 16 generic and 0 brand products.
What is the average price of Amici Pharma, Inc drugs?
The average NADAC across Amici Pharma, Inc's portfolio is $0.4685 per unit, ranging from $0.0625 to $4.5668.
What types of drugs does Amici Pharma, Inc make?
Amici Pharma, Inc makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Angiotensin Converting Enzyme Inhibitor (7), Nonsteroidal Anti-inflammatory Drug (3), Thiazide-like Diuretic (3), Nitroimidazole Antimicrobial (2), Cardiac Glycoside (1).
Has Amici Pharma, Inc had any drug recalls?
No FDA enforcement recalls are matched to Amici Pharma, Inc in the openFDA feed.
How has Amici Pharma, Inc's pricing changed recently?
Over the past 7 days, 8 Amici Pharma, Inc products rose and 8 fell, with a portfolio-wide average change of -1.1%.